Quant HC founder recognized as top woman in MedTech
Thursday, May 11, 2017
Dr. Dana Edelson, the founder and CEO of Quant HC, which develops algorithms for real-time risk stratification of hospitalized patients, was recognized by Becker’s Hospital Review as one of the 110 Women in MedTech to Know for 2017. Dr. Edelson’s company recently launched its flagship analytic, eCART, which enables clinicians to precisely detect inpatients at risk of sepsis, cardiac arrest, and other forms of acute clinical deterioration. eCART currently monitors hundreds of thousands of patients a year, alerting clinicians to those in need of additional resources, and has been shown to decrease cardiac arrests and hospital length of stay.
Dr. Edelson is a graduate of the University of Chicago Pritzker School of Medicine. She completed her residency in internal medicine, a fellowship in hospital medicine, and a masters degree in health studies at the University of Chicago before joining the faculty, where she still practices as a hospitalist. She is an internationally recognized expert in the treatment and prevention of in-hospital cardiac arrest, with a focus in harnessing big data analytics and new technology to identify subtle changes in clinical stability. Her research in cardiac arrest, clinical deterioration and sepsis has been published in high profile journals such as JAMA, Circulation and the American Journal of Respiratory and Critical Medicine and has been cited over 5,000 times.
“I feel honored to be included with so many accomplished women who are committed to changing the practice of medicine,” Dr. Edelson said, “But what I am most proud of is seeing the realization of the years of research from my team. We all went into healthcare to save lives and getting to see this done on a large scale is immensely gratifying.”
Dr. Edelson is one of only three Chicagoans to be recognized this year by Becker’s.